Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Institutional) - Abbott Vascular; Amgen Inc.; AstraZenca; Bristol-Myers Squibb; Bayer AG; Biotronik; Boston Scientific Corporation; Cardinal Health; CardioValve; CSL Behring; Daiichi-Sankyo/Elil Lilly and Company; Edwards Lifesciences; Guerbet; InfraRedx; Johnson&Johnson; Medicure; Medtronic; Novartis; Polares; OrPha Suisse; Pfizer; Regeneron; Sanofi-Aventis; Sinomed; Terumo Medical Corporation; V-Wave